107 related articles for article (PubMed ID: 12665677)
1. Neoadjuvant chemotherapy with ifosfamide and cisplatin combination in advanced head and neck cancer: a retrospective analysis of 519 patients: a single institution experience.
Pai VR; Mazumdar AT; Deshmukh CD; Bakshi AV; Parikh DM; Parikh PM; Mistry RC; Pathak KA
Med Oncol; 2003; 20(1):1-5. PubMed ID: 12665677
[TBL] [Abstract][Full Text] [Related]
2. Two- vs three-drug combination chemotherapy in advanced or recurrent head and neck cancer: a single institution experience of 361 patients.
Pai VR; Mazumdar AT; Deshmukh CD; Bakshi AV; Parikh DM; Parikh PM; Mistry RC; Pathak KA; D'Cruz AK
Med Oncol; 2004; 21(4):305-8. PubMed ID: 15579913
[TBL] [Abstract][Full Text] [Related]
3. Ifosfamide in the treatment of head and neck cancer.
Airoldi M; Cortesina G; Giordano C; Pedani F; Bumma C
Oncology; 2003; 65 Suppl 2():37-43. PubMed ID: 14586145
[TBL] [Abstract][Full Text] [Related]
4. Induction chemotherapy with cisplatin and ifosfamide in locally advanced inoperable squamous cell carcinoma of the head and neck: A single-institution experience.
Zaheer S; Siddiqui SA; Akram M; Hasan SA
Indian J Cancer; 2016; 53(3):372-376. PubMed ID: 28244461
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in paclitaxel-containing chemotherapy for recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Lawhorn K; Hong WK; Lippman SM
Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-33-S19-37. PubMed ID: 9427263
[TBL] [Abstract][Full Text] [Related]
6. Phase II study of high-dose ifosfamide as a single agent and in combination with cisplatin in the treatment of advanced and/or recurrent squamous cell carcinoma of head and neck.
Pai VR; Parikh DM; Mazumdar AT; Rao RS
Oncology; 1993; 50(2):86-91. PubMed ID: 8451041
[TBL] [Abstract][Full Text] [Related]
7. Role of paclitaxel, ifosfamide, and cisplatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
Shin DM; Glisson BS; Khuri FR; Hong WK; Lippman SM
Semin Oncol; 1998 Apr; 25(2 Suppl 4):40-4; discussion 45-8. PubMed ID: 9578061
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.
Shin DM; Glisson BS; Khuri FR; Ginsberg L; Papadimitrakopoulou V; Lee JJ; Lawhorn K; Gillenwater AM; Ang KK; Clayman GL; Callender DL; Hong WK; Lippman SM
J Clin Oncol; 1998 Apr; 16(4):1325-30. PubMed ID: 9552033
[TBL] [Abstract][Full Text] [Related]
9. Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.
Scandurra G; Scibilia G; Banna GL; D'Agate G; Lipari H; Gieri S; Scollo P
J Gynecol Oncol; 2015 Apr; 26(2):118-24. PubMed ID: 25686397
[TBL] [Abstract][Full Text] [Related]
10. Docetaxel, ifosfamide and cisplatin (DIP) in squamous cell carcinoma of the head and neck.
Specenier PM; Van Den Brande J; Schrijvers D; Huizing MT; Altintas S; Dyck J; Van Den Weyngaert D; Van Laer C; Vermorken JB
Anticancer Res; 2009 Dec; 29(12):5137-42. PubMed ID: 20044628
[TBL] [Abstract][Full Text] [Related]
11. The anti-tumour effect of cisplatin and ifosfamide on xenografted squamous cell carcinoma of the head and neck is schedule-dependent.
Sasaki Y; Kjellén E; Ekblad L; Wahlberg P; Mineta H; Wennerberg J
Oral Oncol; 2012 Jan; 48(1):61-6. PubMed ID: 21963040
[TBL] [Abstract][Full Text] [Related]
12. Single-agent paclitaxel and paclitaxel plus ifosfamide in the treatment of head and neck cancer.
Forastiere AA; Urba SG
Semin Oncol; 1995 Jun; 22(3 Suppl 6):24-7. PubMed ID: 7597431
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical trial of cisplatin, 5-fluorouracil, and ifosfamide as treatment for advanced locoregional head and neck carcinoma.
Sánchez Parra M; Churruca C; Paredes A; Lacasta A; López de Argumedo G; Alvárez I; Abad T; Egana L; Guimón E; Piera JM
Am J Clin Oncol; 1999 Feb; 22(1):6-7. PubMed ID: 10025370
[TBL] [Abstract][Full Text] [Related]
14. Dose-finding study of docetaxel added to ifosfamide and cisplatin followed by concomitant capecitabine and radiotherapy in the treatment of locally advanced squamous cell carcinoma of the head and neck.
Recchia F; Saggio G; Cesta A; Amiconi G; di Blasio A; Candeloro G; Valeriani M; Tombolini V; Rea S
Anticancer Res; 2006; 26(3B):2317-24. PubMed ID: 16821609
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of ifosfamide in recurrent squamous cell carcinoma of the head and neck.
Huber MH; Lippman SM; Benner SE; Shirinian M; Dimery IW; Dunnington JS; Hong WK
Am J Clin Oncol; 1996 Aug; 19(4):379-82. PubMed ID: 8677909
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin and ifosfamide with various doses of vinorelbine (navelbine) in advanced non-small lung cancer.
Souquet PJ; Fournel P; Bohas CH; Fortune IC; Chatte G
Semin Oncol; 1996 Apr; 23(2 Suppl 5):8-10. PubMed ID: 8610239
[TBL] [Abstract][Full Text] [Related]
17. The role of ifosfamide and systemic therapy in the management of carcinoma of the cervix.
Thigpen T; Vance R; Khansur T; Malamud F
Semin Oncol; 1996 Jun; 23(3 Suppl 6):56-64. PubMed ID: 8677451
[TBL] [Abstract][Full Text] [Related]
18. Neoadjuvant etoposide, ifosfamide, and cisplatin for the treatment of olfactory neuroblastoma.
Kim DW; Jo YH; Kim JH; Wu HG; Rhee CS; Lee CH; Kim TY; Heo DS; Bang YJ; Kim NK
Cancer; 2004 Nov; 101(10):2257-60. PubMed ID: 15484215
[TBL] [Abstract][Full Text] [Related]
19. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
20. Neoadjuvant docetaxel and cisplatin chemotherapy followed by local irradiation is highly active on locoregionally advanced squamous cell carcinoma of the head and neck.
Shin HJ; Chung JS; Choi YJ; Lee BJ; Wang SG; Kim DW; Cho GJ
J Laryngol Otol; 2008 Jul; 122(7):722-7. PubMed ID: 17925058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
